Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2016

01-07-2016 | Short Report

Causes of liver disease and its outcome in HIV-infected individuals

Published in: Indian Journal of Gastroenterology | Issue 4/2016

Login to get access

Abstract

Liver disease in HIV-infected patients has remained unaddressed in India. This study describes the causes of liver disease in HIV-infected patients and short-term outcome in them. Designed as a prospective observational study, it was conducted at Jawaharlal Institute of Postgraduate Medical Education and Research between September 2011 and March 2013. All consecutive HIV patients (>13 years) attending the antiretroviral therapy clinic or admitted in the Medicine Department were screened, and patients with liver disease or with either HBsAg or anti-HCV antibody positivity were included in the study. Of the 198 patients screened, 51 (26 %) had either abnormal liver function test or had HBsAg or anti-HCV positivity. The median age of the patients was 40 years and 82 % were males. The median CD4 count was 123 cells/mm3. Eighteen (35 %) of them had alcoholic liver disease. Six patients had probable hepatic involvement due to tuberculosis. Ten patients had antituberculosis drug-induced hepatotoxicity. One patient had acute hepatitis B and seven patients had chronic hepatitis B. The cause could not be established in 10 patients (20 %). After a median period of 8 months of follow up, 23 patients had improved, 19 patients (37 %) had died, and six patients had been lost to follow up. Of the patients who had died, 11 patients (58 %) had tuberculosis, and 6 patients (30 %) had decompensated alcoholic liver disease. In conclusion, liver disease in HIV-infected patients was associated with high mortality. Alcohol abuse, tuberculosis, and antituberculosis drugs were the major causes.
Literature
1.
go back to reference Soriano V, Barreiro P, Sherman KE. The changing epidemiology of liver disease in HIV patients. AIDS Rev. 2013;15:25–31.PubMed Soriano V, Barreiro P, Sherman KE. The changing epidemiology of liver disease in HIV patients. AIDS Rev. 2013;15:25–31.PubMed
2.
go back to reference Rathi PM, Amarapurkar DN, Borges NE, et al. Spectrum of liver diseases in HIV infection. Indian J Gastroenterol 1997;16:94–5. Rathi PM, Amarapurkar DN, Borges NE, et al. Spectrum of liver diseases in HIV infection. Indian J Gastroenterol 1997;16:94–5.
5.
go back to reference Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003;5:36–43.PubMed Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003;5:36–43.PubMed
6.
go back to reference Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935–52.CrossRefPubMed Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935–52.CrossRefPubMed
9.
go back to reference Easwaran M, Bazroy J, Jayaseelan V, et al. Prevalence and determinants of alcohol consumption among adult men in a coastal area of South India. Int J Med Sci Public Health. 2015;4:360–4. Easwaran M, Bazroy J, Jayaseelan V, et al. Prevalence and determinants of alcohol consumption among adult men in a coastal area of South India. Int J Med Sci Public Health. 2015;4:360–4.
10.
go back to reference Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. Int J Behav Med. 2014;21:811–20.CrossRefPubMedPubMedCentral Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. Int J Behav Med. 2014;21:811–20.CrossRefPubMedPubMedCentral
11.
go back to reference Hickey AJ, Gounder L, Moosa MY, et al. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis 2015;15:209. Hickey AJ, Gounder L, Moosa MY, et al. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis 2015;15:209.
12.
go back to reference Ali AH, Belachew T, Yami A, et al. Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study. PLoS One 2013; doi: 10.1371/journal.pone.0064622. Ali AH, Belachew T, Yami A, et al. Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study. PLoS One 2013; doi: 10.​1371/​journal.​pone.​0064622.​
14.
go back to reference Rivero A, Mira JA, Pineda JA. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother. 2007;59:342–6.CrossRefPubMed Rivero A, Mira JA, Pineda JA. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother. 2007;59:342–6.CrossRefPubMed
15.
go back to reference Hamide A, Shamanna SB, Balaguru S, et al. Long-term outcome of HIV-infected patients treated at a tertiary care hospital in southern India. Natl Med J India. 2014;27:134–7.PubMed Hamide A, Shamanna SB, Balaguru S, et al. Long-term outcome of HIV-infected patients treated at a tertiary care hospital in southern India. Natl Med J India. 2014;27:134–7.PubMed
16.
go back to reference Sud A, Singh J, Dhiman RK, et al. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001;22:90–2.PubMed Sud A, Singh J, Dhiman RK, et al. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001;22:90–2.PubMed
17.
go back to reference Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol 2006;12:6879–83. Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol 2006;12:6879–83.
18.
go back to reference Saravanan S, Velu V, Kumarasamy N, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13:5015–20.CrossRefPubMedPubMedCentral Saravanan S, Velu V, Kumarasamy N, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13:5015–20.CrossRefPubMedPubMedCentral
19.
go back to reference Puoti M, Spinetti A, Ghezzi A, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000;24:211–7.CrossRefPubMed Puoti M, Spinetti A, Ghezzi A, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000;24:211–7.CrossRefPubMed
20.
go back to reference Sharma SK, Soneja M, Prasad KT, et al. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India. Indian J Med Res. 2014;139:154–60.PubMedPubMedCentral Sharma SK, Soneja M, Prasad KT, et al. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India. Indian J Med Res. 2014;139:154–60.PubMedPubMedCentral
Metadata
Title
Causes of liver disease and its outcome in HIV-infected individuals
Publication date
01-07-2016
Published in
Indian Journal of Gastroenterology / Issue 4/2016
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-016-0676-6

Other articles of this Issue 4/2016

Indian Journal of Gastroenterology 4/2016 Go to the issue